Carregant...
The role of checkpoints in the treatment of GBM
Targeted immunotherapy is founded on the principle that augmentation of effector T cell activity in the tumor microenvironment can translate to tumor regression. Targeted checkpoint inhibitors in the form of agonist or antagonist monoclonal antibodies have come to the fore as a promising strategy to...
Guardat en:
| Publicat a: | J Neurooncol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4750481/ https://ncbi.nlm.nih.gov/pubmed/25749875 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-015-1747-8 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|